Gilead"s Kite announces long-term data from ZUMA-1 study in lymphoma
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BioMarin announces data from long-term extension Phase 3 vosoritide study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Roche Announces Positive Data on Gazyva and MS Drug Ocrevus
Roche (RHHBY) announced positive long-term data on leukemia drug Gazyva and MS drug Ocrevus. Roche RHHBY announced encouraging data from the final analysis of the CLL11 study, evaluating Gazyva-based treatment in previously untreated.....»»
Akari Announces Third Quarter 2018 Financial Results and Business Highlights
Four ongoing clinical trial programs Two clinical programs expected to report initial data in first quarter 2019 Long-term clinical study continues to yield encouraging safety data NEW YORK and LONDON, Nov. 15, 2018 (GLOBE NEWSWIRE) --.....»»
Kite Pharma announces updated Zuma-3 data from KTE-X19 Phase 1/2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ultragenyx announces longer-term data from Glycogen Storage Disease study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Solid Biosciences announces IGNITE DMD long term biopsy data update
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Humacyte announces long-term follow-up data from Phase 2 vascular access trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Exagen announces study on long-term effects of COVID-19 infection
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
MorphoSys announces long-term follow-up results from L-MIND study of tafasitamab
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
OncoCyte announces publication of long-term follow up data for DetermaRx
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Sol-Gel Technologies announces long-term Epsolay safety study results
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ovid Therapeutics expects long-term data from ENDYMION study in 1Q20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Foamix announces publication of AMZEEQ topical foam long-term safety data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
TG Therapeutics announces final long-term results from Phase 3 GENUINE study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Abeona announces publication of long-term data from Phase 1/2a trial of EB-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Kite announces new Yescarta data from ZUMA-1
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Acer Therapeutics announces publication of long-term vEDS patient registry data
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amgen announces new 4-yr outcomes study to examine long-term effects of repatha
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead (GILD) Presents Encouraging Data on NASH Therapies
Gilead Sciences (GILD) announces encouraging data from a proof-of-concept study on experimental combination NASH therapies at The International Liver Congress 2018 in Paris. Gilead Sciences, Inc. GILD announced encouraging data from .....»»
Adverum announces long-term preclinical efficacy data on ADVM-022 gene therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»